Bausch & Lomb (BLCO) Change in Accured Expenses (2021 - 2026)
Bausch & Lomb (BLCO) posted Change in Accured Expenses of -$94.0 million for Q1 2026, down 4600.0% on a QoQ basis from -$2.0 million in Q4 2025, and down 308.7% year-over-year from $45.0 million in Q1 2025.
Bausch & Lomb (BLCO) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Bausch & Lomb's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$94.0 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 308.7% year-over-year to -$94.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.0 million (up 12.12% YoY) and the FY2025 annual result came in at $108.0 million, down 14.29% from the prior year.
- Change in Accured Expenses was -$94.0 million for Q1 2026 at Bausch & Lomb, down from -$2.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $188.0 million in Q4 2023 and bottomed at -$107.0 million in Q4 2024.
- A 5-year average of $33.8 million and a median of $36.0 million in 2025 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 5300.0% in 2023, while the deepest fall reached 325.0% in 2023.
- Bausch & Lomb's Change in Accured Expenses stood at $110.0 million in 2022, then surged by 70.91% to $188.0 million in 2023, then sank by 156.91% to -$107.0 million in 2024, then surged by 98.13% to -$2.0 million in 2025, then sank by 4600.0% to -$94.0 million in 2026.
- Business Quant data shows BLCO's Change in Accured Expenses at -$94.0 million in Q1 2026, -$2.0 million in Q4 2025, and $36.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -260.40 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -151.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 5.38 Mn |
| 10 | Bausch & Lomb | 5.79 Bn | 5.51 Bn | 973.00 Mn | -94.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.00 Mn |
| Mar 31, 2026 | -94.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2025 | 36.00 Mn |
| Jun 30, 2025 | 97.00 Mn |
| Jun 30, 2025 | 97.00 Mn |
| Mar 31, 2025 | -23.00 Mn |
| Mar 31, 2025 | -23.00 Mn |
| Dec 31, 2024 | -107.00 Mn |
| Dec 31, 2024 | -107.00 Mn |
| Sep 30, 2024 | 94.00 Mn |
| Sep 30, 2024 | 94.00 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Dec 31, 2023 | 188.00 Mn |
| Dec 31, 2023 | 188.00 Mn |